Dyne Therapeutics DYN
NASDAQ DYN
$15.68 -0.43 (-2.67%)
As of: Oct 1, 2026 · 12:11 PM EDT

Dyne Therapeutics (DYN) Return on Equity [ROE] (2020 - 2026)

Updated

Dyne Therapeutics (DYN) reported Return on Equity [ROE] of -64.72% for Q2 2026, up 1.44 percentage points from -66.16% a year earlier but down 16.55 percentage points from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Dyne Therapeutics posted Return on Equity [ROE] of -54.72%, up 33.18 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of -21.84 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -87.91% in FY2024 (+48.58 pp), -136.49% in FY2023 (-82.33 pp), -54.16% in FY2022 (-12.14 pp) and -42.02% in FY2021 (-9.14 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -192.76% in Q4 2023 and a high of -29.09% in Q3 2021.
  • Year over year, Return on Equity [ROE] gained in five of the last eight quarters, with an average year-over-year change of +25.84 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 145.30 percentage points); the low point was Q4 2023 (a drop of 125.82 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -48.18% (Q1 2026), -53.05% (Q4 2025) and -66.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Dyne Therapeutics 2.67 Bn 2.67 Bn - -64.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -64.72%
Mar 31, 2026 -48.18%
Dec 31, 2025 -53.05%
Sep 30, 2025 -66.87%
Jun 30, 2025 -66.16%
Mar 31, 2025 -56.36%
Dec 31, 2024 -47.46%
Sep 30, 2024 -39.61%
Jun 30, 2024 -41.03%
Mar 31, 2024 -90.18%
Dec 31, 2023 -192.76%
Sep 30, 2023 -115.56%
Jun 30, 2023 -84.08%
Mar 31, 2023 -71.40%
Dec 31, 2022 -66.94%
Sep 30, 2022 -67.44%
Jun 30, 2022 -58.45%
Mar 31, 2022 -45.37%
Dec 31, 2021 -38.16%
Sep 30, 2021 -29.09%
API Access

Dyne Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DYN&period=max&api_key=YOUR_API_KEY